Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. - Wikidata - awgldk - TriplyDB

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

http://www.wikidata.org/entity/Q30355613

about

Few and far between: how HIV may be evading antibody avidity Cloning, sequence analysis, and expression of the large subunit of the human lymphocyte activation antigen 4F2 Pathogenesis of human immunodeficiency virus infection Structural definition of a conserved neutralization epitope on HIV-1 gp120 An algorithm for mapping positively selected members of quasispecies-type viruses.HIV-1 neutralizing antibodies: understanding nature's pathways Novel approaches to inhibit HIV entry Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125 Structure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry Inhibitors Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12 Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1 Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 What Are the Most Powerful Immunogen Design Vaccine Strategies?Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase Survivors Remorse: antibody-mediated protection against HIV-1.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.HIV-1 envelope subregion length variation during disease progression C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody.HIV-1 and influenza antibodies: seeing antigens in new ways Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120 The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.High levels of heterodisperse RNAs accumulate in T cells infected with human immunodeficiency virus and in normal thymocytes.A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4 Evolutionary origin of human and simian immunodeficiency viruses.Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120 HIV-1 envelope determinants for cell tropism and chemokine receptor use.

P2860

Q21090507-6387797F-445C-40B5-A582-F6DB34408749 Q24631057-729BFCD7-7527-4D8C-8105-AA71C51BFFB0 Q24634681-B930DA48-7D11-46E7-ACE2-67542DAE952C Q24655948-BD533BAC-9D8C-48C3-B00C-2C5E5D812C0B Q24797088-71CAB25B-4660-44EB-937A-C0FA35FE74B8 Q27000480-FDB821D4-623E-447F-8E30-932C41E749DA Q27013957-BD11BA16-27BF-4950-AFBD-E85DDA1FD400 Q27644383-436DCE20-E8C0-42C1-87AF-A35C5E83A76D Q27645052-2ABD214E-D4DB-4B2F-900A-91D339D1E811 Q27658449-DB57BE45-B36C-4B48-92FC-70D7DE37CB48 Q27667679-D6B5363C-583A-480D-BD0D-39C8BF1E66B6 Q27678493-DA1949EE-0A13-4331-B6C5-F1157E448F00 Q27680810-34E1B0D1-767F-44E6-AA70-19A101B5DCCB Q27759364-945DB033-2C64-48CC-BE12-8ECA9850451A Q28320362-B0EAEE23-A487-41CE-972A-0C0D8C30459A Q28367654-079E83B3-FB77-4C8E-8DF5-AFC7BA102160 Q28368034-04650D3B-DD34-4186-98B4-155FC9C9B1C1 Q28476558-0AFAC83C-B206-460A-9FB0-6998F223A5FE Q28487168-2AAB5820-1273-4A4C-8E9F-A02CAFD23CA2 Q28602877-0BDF49E4-613E-499E-BCE0-9B4554538E2B Q28646731-68AA9DAF-5ACE-4BE9-9538-2EB4E6C99233 Q28646771-1BBB9979-6B42-41AB-822D-FEBEF1E775F2 Q28729792-808B1437-E79B-4C42-84F4-F835A6A12767 Q29619512-2D3F3C44-B42D-4B65-829B-9F6838C4EE48 Q29619994-8E6EC319-236E-4CCC-854D-7A4B461BA0D6 Q30238730-FD513AD4-EEE3-426C-B4E7-64295659DF77 Q30353580-DA52B732-5525-401E-8A9D-34F00AF2BF16 Q30356755-5DCF1F4A-44C7-4A00-B1A5-22C8C76289F7 Q30397933-E6627B72-F6C9-4758-85F6-D51274DBF8D5 Q30422545-6AAA86B9-5FAA-4B4E-96DE-EBE768AC9E0B Q32049913-81FC40AA-B2B1-4075-B627-C4EE8387DA01 Q33552488-841B5B8F-6995-4EC2-B919-736F3F905843 Q33560772-F743F8FA-57C7-4B15-BC3C-C1F5BE9EE1F3 Q33571605-0D549020-A16F-48B0-96D3-9287E293BD74 Q33579510-790B2D07-4A46-4CA7-BF65-0AE228CB3933 Q33582974-345E8FE5-615F-4A8C-86D9-FA5493B4EB94 Q33587774-B6A81608-2358-40D2-AD3B-1C60714BC984 Q33604826-6724F971-7D27-4D44-A274-860EE7B46F77 Q33632668-B4CCEE94-8271-43D0-9EFB-EEC393801947 Q33637946-FFFF394B-8508-4E0E-93E6-A89B794297F6

P2860

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

http://www.wikidata.org/entity/Q30355613

description

1986 nî lūn-bûn

@nan

1986 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@ast

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@en

type

label

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@ast

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@en

prefLabel

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@ast

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@en

P1433

Q30355613-876577D4-8250-429E-8B60-ABC72D8CF0BF

P1476

Q30355613-2C782E7E-96AF-461E-9FF3-97BA34AAC39B

P2093

Q30355613-0F0DEC82-D4D1-4794-AB39-1BFC5421952B

Q30355613-40086F8C-C898-4142-B838-E16806C7E9E9

Q30355613-4B7E9EDE-7005-4275-AE39-2F215AD8D12F

Q30355613-69E92AA6-FF3C-486D-8E7B-64F9E14EF1A5

Q30355613-6C3B6BFE-AAFE-4E63-8449-C1E827519A5E

Q30355613-BEB57F9C-2052-42E5-B850-07842BFDBA75

Q30355613-CADC6708-6B63-46B5-B0D9-265B63AB0783

Q30355613-EF6D4631-BAA1-4194-B56F-E5BB06AD5821

Q30355613-F1F2711B-87A3-47C7-8940-2BD8D4CE374E

P304

Q30355613-E64A7EB8-5F86-42D4-8726-2EE86C91C93F

P31

Q30355613-795BCFE1-4A70-4E97-9F2A-D5676282F0DE

P356

Q30355613-06FFFB22-72E1-4D68-9C64-8B92CCC34A91

P407

Q30355613-D3A86763-540A-49F3-920E-5B77136E4205

P433

Q30355613-A02224B9-99A7-41FB-861A-9BA0E4FCD09A

P478

Q30355613-35FAA2BC-B012-4324-8065-95E580880C74

P50

Q30355613-D24D0EE0-CE8F-4118-B8EC-A3E8BC822835

P577

Q30355613-DE76755A-B4EB-4E2A-B141-C1EF3A1321A7

P5875

Q30355613-F2A0955C-1DCC-48E9-9BAD-FB3A62A30496

P698

Q30355613-D8E56E86-FB1E-4713-B5CF-0B5276EECB40

P921

Q30355613-AA59DB2F-E915-4A5F-9968-86C56D321ED8

P356

0092-8674(86)90778-6

P1433

P1476

Identification and characteriz ...... I/LAV, the retrovirus of AIDS.

@en

P2093

Hahn BH

http://www.w3.org/2001/XMLSchema#string

Josephs SF

http://www.w3.org/2001/XMLSchema#string

McNeely PD

http://www.w3.org/2001/XMLSchema#string

Modrow S

http://www.w3.org/2001/XMLSchema#string

Parks ES

http://www.w3.org/2001/XMLSchema#string

Parks WP

http://www.w3.org/2001/XMLSchema#string

Shaw GM

http://www.w3.org/2001/XMLSchema#string

Starcich BR

http://www.w3.org/2001/XMLSchema#string

Wolf H

http://www.w3.org/2001/XMLSchema#string

P304

637-648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0092-8674(86)90778-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

P577

1986-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20733359

http://www.w3.org/2001/XMLSchema#string

P698

2423250

http://www.w3.org/2001/XMLSchema#string

P921